Centre Hospitalier De Pau

The clinical trial portfolio at Centre Hospitalier De Pau includes important work in cardiovascular diseases, especially atrial fibrillation and acute coronary syndrome. These studies are focused on improving the prevention of serious heart- and stroke-related events and on comparing new treatment options with current standard care.

• Preventing stroke and other embolic complications in atrial fibrillation
• Reducing major cardiovascular events after heart attack or related acute coronary syndrome
• Evaluating whether new therapies can improve protection beyond existing treatment approaches

This area reflects a strong interest in safer and more effective long-term management of cardiovascular disease.

Research in digestive system diseases is a major focus at this hospital, with trials addressing ulcerative colitis and bowel urgency. The goal is to better control symptoms, improve remission rates, and support patients living with chronic inflammatory bowel conditions.

• Improving symptom control in moderately to severely active ulcerative colitis
• Testing new treatments aimed at achieving clinical remission and endoscopic improvement
• Assessing whether therapies can reduce bowel urgency and improve daily quality of life

These studies highlight ongoing efforts in gastroenterology to refine treatment options for persistent digestive inflammation.

The oncology trials at Centre Hospitalier De Pau cover several neoplasms, including melanoma, small bowel adenocarcinoma, colon carcinoma, advanced non-small cell lung cancer, and cutaneous squamous cell carcinoma. These studies are designed to evaluate new cancer treatments, improve disease control, and extend the time patients remain free from progression or recurrence.

• Testing treatment strategies for melanoma and high-risk resected disease
• Exploring new options for small bowel adenocarcinoma, colon cancer, and lung cancer
• Assessing therapies for advanced cutaneous squamous cell carcinoma that is difficult to treat with surgery or radiotherapy

Overall, this research aims to improve outcomes in both early and advanced cancer settings through better treatment selection and disease control.

Another part of the site’s research activity focuses on digestive system and oral physiological phenomena, with studies designed to understand how patients respond to therapy and how symptoms change over time. This work supports more personalized care in gastroenterology by linking symptom relief with treatment effectiveness.

• Monitoring changes in digestive symptoms during treatment for ulcerative colitis
• Evaluating how well therapies improve patient-reported digestive comfort and function
• Supporting research that connects symptom improvement with broader disease control

These investigations complement the site’s broader focus on chronic digestive disease management and patient-centered outcomes.